Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group.
Saved in:
| Title: | Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group. |
|---|---|
| Authors: | Minarik J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic. abretina@email.cz., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic., Latal V; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic., Jelinek T; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Straub J; 1st Medical Department - Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Jungova A; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic., Radocha J; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Faculty of Medicine Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Pavlicek P; Department of Internal Medicine and Hematology, 3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic., Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic., Pika T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic., Krhovska P; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic., Popkova T; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Sedlak F; 1st Medical Department - Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Spicka I; 1st Medical Department - Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic., Jindra P; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic., Capounova V; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Faculty of Medicine Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Maisnar V; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Faculty of Medicine Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Hajek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. |
| Source: | BMC cancer [BMC Cancer] 2025 Apr 09; Vol. 25 (1), pp. 651. Date of Electronic Publication: 2025 Apr 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-025-14087-y |
